It is a key newly emerging variant with great potential for immune escape, thus highly relevant for the EuCARE in vitro studies. EuCARE continues its commitment to collect newly emergent live SARS-CoV-2 variants to keep pace with ongoing virus evolution and secure the appropriate material for advancing knowledge on SARS-CoV-2 immunity.
